The most common clinical syndromes that cause nasal congestion are allergic rhinitis, vasomotor rhinitis, chronic sinusitis, and upper respiratory viral infections (common colds). Nasal congestion, in turn, can lead to sequelae such as sinusitis, otitis media, and the onset or worsening of mild to severe sleep disturbances, including obstructive sleep apnea. There is a host of conservative treatments, including decongestant pharmacotherapy, antiallergy measures, and nasal dilation devices. Several surgical procedures are also available. This article reviews the current guidelines for the workup and diagnosis of nasal congestion and briefly describes the many and varied approaches to treatment.
References
1.
International Consensus Report on the diagnosis and management of rhinitis.International Rhinitis Management Working Group. Allergy1994; 49(19 Suppl): 1–34.
2.
KimmelmanC.P.The problem of nasal obstruction. Otolaryngol Clin North Am1989; 22: 253–64.
3.
HadleyJ.A.Overview of otolaryngic allergy management. An eclectic and cost-effective approach. Otolaryngol Clin North Am1998; 31: 69–82.
4.
MabryR.L.Rhinitis medicamentosa: The forgotten factor in nasal obstruction. South Med J1982; 75: 817–9.
RoithmannR., ColeP., ChapnikJ.Acoustic rhinometry in the evaluation of nasal obstruction. Laryngoscope1995; 105: 275–81.
7.
SzucsE., ClementP.A.Acoustic rhinometry and rhinomanometry in the evaluation of nasal patency of patients with nasal septal deviation. Am J Rhinol1998; 12: 345–52.
8.
LundV.J., FloodJ., SykesA.P., RichardsD.H.Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg1998; 124: 513–8.
9.
PorterM., WilliamsonI., KerridgeD., MawR.Manometric rhinometry: A new method of measuring nasal volume. Rhinology1995; 33: 86–8.
10.
NadelD.M., LanzaD.C., KennedyD.W.Endoscopically guided cultures in chronic sinusitis. Am J Rhinol1998; 12: 233–41.
11.
CoreyJ.P.Chronic rhinitis: The differential diagnosis. Hosp Med1996; 32(3 Suppl): 3–8.
12.
GrafP., HallenH., JutoJ.E.Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity. Acta Otolaryngol1995; 115: 71–5.
PetrusonB., HanssonH.A.Function and structure of the nasal mucosa after 6 weeks’ use of nose-drops. Acta Otolaryngol1982; 94: 563–9.
15.
GrafP., HallenH.Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope1996; 106: 605–9.
16.
OlsenK.D., KernE.B.Nasal influences on snoring and obstructive sleep apnea. Mayo Clin Proc1990; 65: 1095–105.
17.
RundcrantzH.Postural variations of nasal patency. Acta Otolaryngol1969; 69: 435–43.
18.
YoungT., FinnL., KimH.Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol1997; 99: S757–62.
19.
MartinS.E., EnglemanH.M., DearyI.J., DouglasN.J.The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med1996; 153: 1328–32.
20.
LavieP., GertnerR., ZomerJ., PodoshinL.Breathing disorders in sleep associated with “microarousals” in patients with allergic rhinitis. Acta Otolaryngol1981; 92: 529–33.
21.
CraigT.J., TeetsS., LehmanE.B.Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol1998; 101: 633–7.
22.
CarskadonM.A., BearparkH.M., SharkeyK.M.Effects of menopause and nasal occlusion on breathing during sleep. Am J Respir Crit Care Med1997; 155: 205–10.
23.
SerpellM.G., PadghamN., McQueenF.The influence of nasal obstruction and its relief on oxygen saturation during sleep and the early postoperative period. Anaesthesia1994; 49: 538–40.
WetmoreS.J., ScrimaL., HillerF.C.Sleep apnea in epistaxis patients treated with nasal packs. Otolaryngol Head Neck Surg1988; 98: 596–9.
26.
LoftusB.C., BlitzerA., CozineK.Epistaxis, medical history, and the nasopulmonary reflex: What is clinically relevant?Otolaryngol Head Neck Surg1994; 110: 363–9.
27.
McNicholasW.T., TarloS., ColeP.Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis1982; 126: 625–8.
28.
HeimerD., ScharfS.M., LiebermanA., LavieP.Sleep apnea syndrome treated by repair of deviated nasal septum. Chest1983; 84: 184–5.
29.
KrauseH.F.Antihistamines and decongestants. Otolaryngol Head Neck Surg1992; 107: 835–40.
30.
FiremanP.Treatment strategies designed to minimize medical complications of allergic rhinitis. Am J Rhinol1997; 11: 95–102.
31.
ConnellJ.T.A novel method to assess antihistamine and decongestant efficacy. Ann Allergy1979; 42: 278–85.
32.
FalliersC.J., ReddingM.A.Controlled comparison of a new antihistamine-decongestant combination to its individual components. Ann Allergy1980; 45: 75–80.
33.
HilbergO.Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy1995; 50: 683–8.
34.
RatnerP.H., van BavelJ.H., MartinB.G.A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract1998; 47: 118–25.
35.
BarnesP.J., PedersenS.Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis1993; 148: S1–S26.
36.
KingH.C.Mast cell stabilizers. Otolaryngol Head Neck Surg1992; 107: 841–4.
37.
MeltzerE.O.An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol1995; 95: 1097–110.
38.
FornadleyJ.Allergy immunotherapy. Otolaryngol Clin North Am1998; 31: 111–27.
39.
BronskyE.A., DruceH., FindlayS.R.A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol1995; 95: 1117–22.
40.
ChaudhryM.R., AkhtarS., DwalsaintF.Rhinomanometric evaluation of the improved mechanical therapeutic nasal dilator in patients with anterior nasal obstruction. Rhinology1996; 34: 32–4.
41.
WangC.H., LinH.C., HuangT.J.Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction. Eur Respir J1996; 9: 952–9.
42.
Warwick-BrownN.P., MarksN.J.Turbinate surgery: How effective is it? A long-term assessment. ORL J Otorhinolaryngol Relat Spec1987; 49: 314–20.
43.
GrymerL.F., IliumP., HilbergO.Septoplasty and compensatory inferior turbinate hypertrophy: A randomized study evaluated by acoustic rhinometry. J Laryngol Otol1993; 107: 413–7.
44.
MaraisJ., MurrayJ.A., MarshallI.Minimal cross-sectional areas, nasal peak flow and patients’ satisfaction in septoplasty and inferior turbinectomy. Rhinology1994; 32: 145–7.
45.
ElwanyS., ThabetH.Obstruction of the nasal valve. J Laryngol Otol1996; 110: 221–4.
46.
BohlinL., DahlqvistA.Nasal airway resistance and complications following functional septoplasty: A ten-year follow-up study. Rhinology1994; 32: 195–7.
